Oral THC

DRUG2 trials

Sponsors

University of California, Davis, Johns Hopkins University

Conditions

Behavioral Pharmacology of CannabinoidsMultiple Sclerosis

Early Phase 1

The Pharmacodynamics of Cannabinoid-Caffeine Combinations

CompletedNCT05478863

Johns Hopkins UniversityBehavioral Pharmacology of Cannabinoids

Start: 2023-01-20End: 2024-10-02Updated: 2024-10-08

Phase 1

Cannabis for Spasticity in Multiple Sclerosis

TerminatedNCT00682929

University of California, DavisMultiple Sclerosis

Start: 2004-04-14End: 2011-08-17Updated: 2018-05-18